Intraoperative recombinant activated factor VII for emergent epidural hematoma evacuation

Anesthesia and Analgesia

Volumn 99, Issue 2, 2004, Pages 595-597

  Szabo, Tamas ^a   Ali, Syed ^a   Camporesi, Enrico M ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; FRESH FROZEN PLASMA; VITAMIN K GROUP;

ADULT; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; CASE REPORT; CAUDA EQUINA SYNDROME; DRUG EFFECT; EPIDURAL HEMATOMA; FEMALE; HEMOSTASIS; HUMAN; INTRAOPERATIVE PERIOD; LAMINECTOMY; LOW BACK PAIN; NERVE COMPRESSION; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

EID: 3242756525     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000130394.85483.C7     Document Type: Article

References (18)

1. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)-Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996;348:423-8.
2. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119:S22-38.
3. Hedner U. NovoSeven as a universal haemostatic agent. Blood Coagul Fibrinolysis 2000;11:S107-11.
4. Hoffman M, Monroe DM, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998;9:S61-5.
5. Peerlinck K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophilia A and inhibitor. Thromb Haemost 1999;82:1775-6.
6. Rosenfeld SB, Watkinson KK, Thompson BH, et al. Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient. Thromb Haemost 2002;87:925-6.
7. Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002;137:884-8.
8. Friederich PW, Henry CP, Messelink EJ, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomized trial. Lancet 2003;361:201-5.
9. Tobias JD. Synthetic factor VIIa to treat dilutional coagulopathy during posterior spinal fusion in two children. Anesthesiology 2002;96:1522-5.
10. Slappendel R, Huvers FC, Benraad B, et al. Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia. Anesthesiology 2002;96:1525-7.
11. von Heymann C, Hotz H, Konertz W, et al. Successful treatment of refractory bleeding with recombinant factor VIIa after redo coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2002;16:615-6.
12. Kastrup M, von Heymann C, Hotz H, et al. Recombinant factor VIIa (rFVIIa) after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg 2002;74:910-2.
13. Hendriks HG, van der Maaten JM, de Wolf J, et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001;93:287-9.
14. Zietkiewicz M, Garlicki M, Domagala J, et al. Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device. J Thorac Cardiovasc Surg 2002;123:384-5.
15. Sheth S, Dimichele D, Lee M, et al. Heart transplant in a factor VIII-deficient patient with a high-titre inhibitor: perioperative management using high-dose continuous infusion factor VIII and recombinant factor VIIa. Haemophilia 2001;7:227-32.
16. Lin J, Hanigan WC, Tarantino M, et al. The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings. J Neurosurg 2003;98:737-40.
17. Park P, Fewel ME, Garton HJ, et al. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery 2003;53:34-8.
18. Veschev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit 2002;8:CS98-100.